We stand at the frontiers of chemistry and biology, developing small molecules as chemical tools to understand and modulate complex biological systems. We utilize synthetic chemistry, biochemistry, and state-of-the art mass spectrometry to elucidate the structure, dynamics, and reactivity of poorly characterized, previously "undruggable" members of the proteome with pathological implications (e.g. cancer, diabetes, infectious diseases).